Lab-Grown mini tumors could predict best lung cancer therapy
NCT ID NCT03655015
First seen Apr 15, 2026 · Last updated Apr 28, 2026 · Updated 2 times
Summary
This study creates a 'living biobank' of miniature lung tumors (organoids) from 150 patients with early-stage lung cancer. Researchers will test how these lab-grown tumors respond to chemotherapy and targeted drugs, comparing results to what happens in the patient. The goal is to learn whether these organoids can reliably predict which treatment will work best for each person, paving the way for more personalized care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UT Health San Antonio, M.D. Anderson Cancer Center
RECRUITINGSan Antonio, Texas, 78229, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.